Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

NPPA Expands Ringer Lactate Price List, Adds Five Manufacturers and New Pack Types

Susmita Roy8 Nov 2025 10:14 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has issued an addendum to its earlier orders...

NPPA Fixes Ceiling Prices for 6 Life-Saving Drugs Including Immunoglobulin, Dialysis Fluids, Riboflavin

Susmita Roy7 Nov 2025 7:29 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of...

Torrent Pharma Slapped with Rs 41.33 Crore GST Penalty for Alleged Erroneous Export Refunds

Torrent Pharma Gets CDSCO Panel Nod to Manufacture, Market Prucalopride Oral Solution

Susmita Roy7 Nov 2025 6:31 PM IST

New Delhi: In a significant regulatory development, Torrent Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) under the...

NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, Details

Susmita Roy6 Nov 2025 11:38 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of...

Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosis

Dr. Reddy's Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment

Susmita Roy6 Nov 2025 3:17 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Dr. Reddy's...

Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on Deleveraging

Susmita Roy6 Nov 2025 2:41 PM IST

New Delhi: Solara Active Pharma Sciences Limited has reported a consolidated net loss of Rs 10.1 crore for the quarter ended September 30, 2025 (Q2...

NPPA Continues Price Cap on Orthopedic Knee Replacement Implants for Another Year Till November 15, 2026

Knee Implant Prices Under Fresh Review: NPPA Weighs 10% Hike Request from Manufacturers

Susmita Roy5 Nov 2025 9:58 PM IST

New Delhi: India's drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), is planning to review the ceiling prices of knee...

Semaglutide Patent War: Novo Nordisk Moves Delhi HC Against Sun Pharma

Major Relief for SBSF College of Pharmacy: Delhi HC Orders PCI to Evaluate D.Pharm Affiliation

Susmita Roy5 Nov 2025 5:09 PM IST

New Delhi: In a major relief to SBSF College of Pharmacy, the Delhi High Court has directed the Pharmacy Council of India (PCI) to process and decide...

JnJ bags USFDA nod for Akeega plus prednisone for prostate cancer

CDSCO Panel Approves Updated Package Insert for Johnson and Johnson's Stelara

Susmita Roy5 Nov 2025 4:51 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for the updated...

Maharashtra Faces Pharmacy Admission Slump Despite 38 New Colleges, Only 48% Students Confirm Seats

Susmita Roy5 Nov 2025 4:29 PM IST

Mumbai: Maharashtra's Bachelor of Pharmacy (B Pharm) admissions have once again hit a roadblock, with thousands of seats likely to go unfilled this...

CDSCO Panel Approves Updated Package Insert for Takeda's Vedolizumab

Susmita Roy5 Nov 2025 4:16 PM IST

New Delhi: In a key regulatory development, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has...

CDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin Study

Susmita Roy4 Nov 2025 4:39 PM IST

New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major revisions in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok